These panels should include a variety of makers to ensure accurate diagnosis, as seen by the presence of TLE1 in synovial sarcoma (Figure 13) or MDM2 in liposarcoma (Figure 4) [25,26]. This evidence concerns the gene MDM2 and liposarcoma.